{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T00:29:12Z","timestamp":1777681752827,"version":"3.51.4"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.bioorg.2026.109861","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:57:11Z","timestamp":1775782631000},"page":"109861","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A non-conjugated peptide-adjuvant system of synthetic peptide-vaccine elicited potent antibody response and opsonic protection against clinical GAS strains"],"prefix":"10.1016","volume":"176","author":[{"given":"Jingyi","family":"Fan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeinab G.","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waleed M.","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Istvan","family":"Toth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariusz","family":"Skwarczynski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel J.","family":"Stephenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.109861_bb0005","doi-asserted-by":"crossref","DOI":"10.1098\/rsos.201991","article-title":"A brief review on group a streptococcus pathogenesis and vaccine development","volume":"8","author":"Castro","year":"2021","journal-title":"R. Soc. Open Sci."},{"key":"10.1016\/j.bioorg.2026.109861_bb0010","article-title":"Recent advances in the development of peptide vaccines and their delivery systems against group A streptococcus","volume":"7","author":"Azuar","year":"2019","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.bioorg.2026.109861_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines12030272","article-title":"Recent scientific advancements towards a vaccine against group a streptococcus","volume":"12","author":"Fan","year":"2024","journal-title":"Vaccines"},{"key":"10.1016\/j.bioorg.2026.109861_bb0020","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/s41579-023-00865-7","article-title":"Pathogenesis, epidemiology and control of group a streptococcus infection","volume":"21","author":"Brouwer","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.bioorg.2026.109861_bb0025","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41541-023-00730-x","article-title":"Update on the development of group a streptococcus vaccines","volume":"8","author":"Ajay Castro","year":"2023","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.bioorg.2026.109861_bb0030","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1084\/jem.161.1.113","article-title":"Multiple, heart-cross-reactive epitopes of streptococcal m proteins","volume":"161","author":"Dale","year":"1985","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bioorg.2026.109861_bb0035","doi-asserted-by":"crossref","first-page":"402","DOI":"10.4161\/viru.2.5.16342","article-title":"The m protein of group a streptococcus is a key virulence factor and a clinically relevant strain identification marker","volume":"2","author":"Metzgar","year":"2011","journal-title":"Virulence"},{"key":"10.1016\/j.bioorg.2026.109861_bb0040","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/femsre\/fux057","article-title":"Group a streptococcal m-like proteins: from pathogenesis to vaccine potential","volume":"42","author":"Frost","year":"2018","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.bioorg.2026.109861_bb0045","doi-asserted-by":"crossref","first-page":"1069789","DOI":"10.3389\/fmicb.2023.1069789","article-title":"Group a streptococci induce stronger m protein-fibronectin interaction when specific human antibodies are bound","volume":"14","author":"Wrighton","year":"2023","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.bioorg.2026.109861_bb0050","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1186\/s13063-024-08634-4","article-title":"A phase 1 randomized controlled trial of a peptide-based group a streptococcal vaccine in healthy volunteers","volume":"25","author":"Meier-Stephenson","year":"2024","journal-title":"Trials"},{"key":"10.1016\/j.bioorg.2026.109861_bb0055","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF02788751","article-title":"The optimization of helper t lymphocyte (HTL) function in vaccine development","volume":"18","author":"Alexander","year":"1998","journal-title":"Immunol. Res."},{"key":"10.1016\/j.bioorg.2026.109861_bb0060","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.4049\/jimmunol.164.3.1625","article-title":"Linear PADRE t helper epitope and carbohydrate b cell epitope conjugates induce specific high titer IgG antibody responses","volume":"164","author":"Alexander","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.bioorg.2026.109861_bb0065","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/S0264-410X(98)00341-7","article-title":"Pan DR binding sequence provides t-cell help for induction of protective antibodies against plasmodium yoelii sporozoites","volume":"17","author":"Franke","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.bioorg.2026.109861_bb0070","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1093\/infdis\/jis107","article-title":"Clinical evaluation of safety and immunogenicity of PADRE-cytomegalovirus (CMV) and tetanus-CMV fusion peptide vaccines with or without PF03512676 adjuvant","volume":"205","author":"La Rosa","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bioorg.2026.109861_bb0075","doi-asserted-by":"crossref","first-page":"282","DOI":"10.2174\/156720111795256192","article-title":"Peptide-based subunit nanovaccines","volume":"8","author":"Skwarczynski","year":"2011","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.bioorg.2026.109861_bb0080","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1039\/C5SC03892H","article-title":"Peptide-based synthetic vaccines","volume":"7","author":"Skwarczynski","year":"2016","journal-title":"Chem. Sci."},{"key":"10.1016\/j.bioorg.2026.109861_bb0085","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/978-1-0716-1892-9_8","article-title":"Developments in vaccine adjuvants","volume":"2412","author":"Firdaus","year":"2022","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bioorg.2026.109861_bb0090","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.it.2008.09.006","article-title":"New horizons in adjuvants for vaccine development","volume":"30","author":"Reed","year":"2009","journal-title":"Trends Immunol."},{"key":"10.1016\/j.bioorg.2026.109861_bb0095","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.coi.2020.08.008","article-title":"New horizons in adjuvants for vaccine development","volume":"65","author":"Reed","year":"2020","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.bioorg.2026.109861_bb0100","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41392-023-01557-7","article-title":"Vaccine adjuvants: mechanisms and platforms","volume":"8","author":"Zhao","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bioorg.2026.109861_bb0105","doi-asserted-by":"crossref","first-page":"5742","DOI":"10.1002\/anie.201002221","article-title":"Polyacrylate dendrimer nanoparticles: a self-adjuvanting vaccine delivery system","volume":"49","author":"Skwarczynski","year":"2010","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.bioorg.2026.109861_bb0110","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1039\/C6TB01131D","article-title":"Nanomaterial-based vaccine adjuvants","volume":"4","author":"Sun","year":"2016","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.bioorg.2026.109861_bb0115","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.2217\/nnm.14.187","article-title":"Recent advances in peptide-based subunit nanovaccines","volume":"9","author":"Skwarczynski","year":"2014","journal-title":"Nanomedicine (Lond.)"},{"key":"10.1016\/j.bioorg.2026.109861_bb0120","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.eurpolymj.2017.02.014","article-title":"The application of self-assembled nanostructures in peptide-based subunit vaccine development","volume":"93","author":"Zhao","year":"2017","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.bioorg.2026.109861_bb0125","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3390\/immuno4040021","article-title":"Self-assembling peptides for vaccine adjuvant discovery","volume":"4","author":"Fan","year":"2024","journal-title":"Immuno"},{"key":"10.1016\/j.bioorg.2026.109861_bb0130","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2020.598160","article-title":"Supramolecular self-assembled peptide-based vaccines: current state and future perspectives","volume":"8","author":"Abdullah","year":"2020","journal-title":"Front. Chem."},{"key":"10.1016\/j.bioorg.2026.109861_bb0135","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nantod.2016.02.004","article-title":"Self-assembled peptide-based nanostructures: smart nanomaterials toward targeted drug delivery","volume":"11","author":"Habibi","year":"2016","journal-title":"Nano Today"},{"key":"10.1016\/j.bioorg.2026.109861_bb0140","article-title":"Polymeric nanoparticles as oral and intranasal peptide vaccine delivery systems: the role of shape and conjugation","volume":"12","author":"Koirala","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.bioorg.2026.109861_bb0145","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1039\/D1BM01333E","article-title":"Physical mixture of a cyclic lipopeptide vaccine induced high titres of opsonic IgG antibodies against group a streptococcus","volume":"10","author":"Madge","year":"2021","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.bioorg.2026.109861_bb0150","first-page":"1","article-title":"Polymeric nanoparticles as a self-Adjuvanting peptide vaccine delivery system: the role of shape","volume":"12","author":"Koirala","year":"2023","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.bioorg.2026.109861_bb0155","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.actbio.2021.05.003","article-title":"Peptide-based supramolecular vaccine systems","volume":"133","author":"O'Neill","year":"2021","journal-title":"Acta Biomater."},{"key":"10.1016\/j.bioorg.2026.109861_bb0160","article-title":"Advances in infectious disease vaccine adjuvants","volume":"10","author":"Fan","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.bioorg.2026.109861_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121614","article-title":"Structure-activity relationship of lipid, cyclic peptide and antigen rearrangement of physically mixed vaccines","volume":"617","author":"Huang","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioorg.2026.109861_bb0170","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41541-024-01050-4","article-title":"A synthetic cyclic peptide for promoting antigen presentation and immune activation","volume":"10","author":"Zhang","year":"2025","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.bioorg.2026.109861_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2020.111539","article-title":"Functionalised peptide hydrogel for the delivery of cardiac progenitor cells","volume":"119","author":"Burgess","year":"2021","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"10.1016\/j.bioorg.2026.109861_bb0180","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1073\/pnas.0912124107","article-title":"A self-assembling peptide acting as an immune adjuvant","volume":"107","author":"Rudra","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bioorg.2026.109861_bb0185","doi-asserted-by":"crossref","first-page":"eaax2285","DOI":"10.1126\/sciadv.aax2285","article-title":"Poly(amino acids) as a potent self-adjuvanting delivery system for peptide-based nanovaccines","volume":"6","author":"Skwarczynski","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bioorg.2026.109861_bb0190","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.biomaterials.2018.01.033","article-title":"Nanofibrous peptide hydrogel elicits angiogenesis and neurogenesis without drugs, proteins, or cells","volume":"161","author":"Moore","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioorg.2026.109861_bb0195","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1021\/acs.accounts.6b00553","article-title":"Self-assembling multidomain peptide nanofibers for delivery of bioactive molecules and tissue regeneration","volume":"50","author":"Moore","year":"2017","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.bioorg.2026.109861_bb0200","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201601776","article-title":"A powerful CD8(+) T-cell stimulating D-tetra-peptide hydrogel as a very promising vaccine adjuvant","volume":"29","author":"Luo","year":"2017","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bioorg.2026.109861_bb0205","first-page":"3","article-title":"Fundamentals of modern peptide synthesis","volume":"298","author":"Amblard","year":"2005","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bioorg.2026.109861_bb0210","first-page":"17","article-title":"Methods for removing the fmoc group","volume":"35","author":"Fields","year":"1994","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bioorg.2026.109861_bb0215","doi-asserted-by":"crossref","unstructured":"B.P.F. Ross, R. A.; Thot, I, N-1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl (N-Dde) lipoamino acids, Molbank, (2008) 1\u20136.","DOI":"10.3390\/M566"},{"key":"10.1016\/j.bioorg.2026.109861_bb0220","doi-asserted-by":"crossref","first-page":"5218","DOI":"10.1021\/ol3007925","article-title":"Acid-mediated prevention of aspartimide formation in solid phase peptide synthesis","volume":"14","author":"Michels","year":"2012","journal-title":"Org. Lett."},{"key":"10.1016\/j.bioorg.2026.109861_bb0225","doi-asserted-by":"crossref","first-page":"5387","DOI":"10.1021\/acs.jmedchem.0c00203","article-title":"Structure-activity analysis of cyclic multicomponent lipopeptide self-Adjuvanting vaccine candidates presenting group a streptococcus antigens","volume":"63","author":"Madge","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109861_bb0230","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/978-1-0716-3914-6_16","article-title":"An analytical protocol for detecting antibody titer levels in serum\/saliva by indirect enzyme-linked immunosorbent assay (ELISA)","volume":"2821","author":"Wang","year":"2024","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bioorg.2026.109861_bb0235","first-page":"433","article-title":"Modified ELISA for antibody avidity evaluation: the need for standardization","volume":"44","author":"Correa","year":"2021","journal-title":"Biom. J."},{"key":"10.1016\/j.bioorg.2026.109861_bb0240","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/infdis\/159.4.736","article-title":"Recent primary toxoplasma infection indicated by a low avidity of specific IgG","volume":"159","author":"Hedman","year":"1989","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bioorg.2026.109861_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2022.113387","article-title":"Study of avidity-ELISA: comparison of chaotropic agents, incubation temperature and affinity maturation after meningococcal immunization","volume":"512","author":"Portilho","year":"2023","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.bioorg.2026.109861_bb0250","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1186\/s12936-019-3014-5","article-title":"Comparison of immunogenicity and safety outcomes of a malaria vaccine FMP013\/ALFQ in rhesus macaques (macaca mulatta) of indian and chinese origin","volume":"18","author":"Martin","year":"2019","journal-title":"Malar. J."},{"key":"10.1016\/j.bioorg.2026.109861_bb0255","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1128\/CVI.13.1.33-36.2006","article-title":"Immunoglobulin g avidity in differentiation between early and late antibody responses to west nile virus","volume":"13","author":"Fox","year":"2006","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.bioorg.2026.109861_bb0260","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/jcla.1860080105","article-title":"Evaluation of protein-denaturing immunoassays for avidity of immunoglobulin g to rubella virus","volume":"8","author":"Polanec","year":"1994","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.bioorg.2026.109861_bb0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/vaccines8020210","article-title":"Opsonic activity of conservative versus variable regions of the group a streptococcus m protein","volume":"8","author":"Dai","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.bioorg.2026.109861_bb0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics14102151","article-title":"Development of multilayer nanoparticles for the delivery of peptide-based subunit vaccine against group a streptococcus","volume":"14","author":"Kiong","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bioorg.2026.109861_bb0275","doi-asserted-by":"crossref","first-page":"7819","DOI":"10.1038\/s41598-017-07908-z","article-title":"Small amphipathic peptides are responsible for the assembly of cruciferin nanoparticles","volume":"7","author":"Hong","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.109861_bb0280","doi-asserted-by":"crossref","first-page":"12094","DOI":"10.1021\/jp2032324","article-title":"Polarity inversion of zeta-potential in concentrated colloidal dispersions","volume":"115","author":"Manzanilla-Granados","year":"2011","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.bioorg.2026.109861_bb0285","doi-asserted-by":"crossref","first-page":"13379","DOI":"10.1021\/acs.langmuir.1c02056","article-title":"Zeta potential and colloidal stability predictions for inorganic nanoparticle dispersions: effects of experimental conditions and electrokinetic models on the interpretation of results","volume":"37","author":"Pochapski","year":"2021","journal-title":"Langmuir"},{"key":"10.1016\/j.bioorg.2026.109861_bb0290","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.bpj.2022.03.003","article-title":"Investigating the effects of n-terminal acetylation on KFE8 self-assembly with 2D IR spectroscopy","volume":"121","author":"Weeks","year":"2022","journal-title":"Biophys. J."},{"key":"10.1016\/j.bioorg.2026.109861_bb0295","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.7150\/thno.53139","article-title":"Encapsulation of LXR ligand by D-nap-GFFY hydrogel enhances anti-tumorigenic actions of LXR and removes LXR-induced lipogenesis","volume":"11","author":"Feng","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.bioorg.2026.109861_bb0300","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1021\/acs.jmedchem.0c01660","article-title":"Poly(hydrophobic amino acid)-based self-Adjuvanting nanoparticles for group a streptococcus vaccine delivery","volume":"64","author":"Azuar","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109861_bb0305","first-page":"1","article-title":"An overview of vaccine adjuvants: current evidence and future perspectives","volume":"10","author":"Facciola","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.bioorg.2026.109861_bb0310","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1016\/j.vaccine.2005.10.046","article-title":"Low-dose intraperitoneal freund's adjuvant: toxicity and immunogenicity in mice using an immunogen targeting amyloid-beta peptide","volume":"24","author":"Oscherwitz","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.bioorg.2026.109861_bb0315","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.micpath.2007.06.006","article-title":"Effects of a th1- versus a th2-biased immune response in protection against helicobacter pylori challenge in mice","volume":"44","author":"Taylor","year":"2008","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.bioorg.2026.109861_bb0320","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.4049\/jimmunol.1401031","article-title":"Dissecting the contribution of IgG subclasses in restricting airway infection with legionella pneumophila","volume":"193","author":"Weber","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.bioorg.2026.109861_bb0325","doi-asserted-by":"crossref","first-page":"5358","DOI":"10.4049\/jimmunol.174.9.5358","article-title":"The influence of immune complex-bearing follicular dendritic cells on the IgM response, ig class switching, and production of high affinity IgG","volume":"174","author":"Aydar","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.bioorg.2026.109861_bb0330","doi-asserted-by":"crossref","first-page":"582","DOI":"10.4049\/jimmunol.2100781","article-title":"IgM to IgG class switching is a necessary step for pemphigus phenotype induction in desmoglein 3-specific b cell receptor knock-in mouse","volume":"208","author":"Nomura","year":"2022","journal-title":"J. Immunol."},{"key":"10.1016\/j.bioorg.2026.109861_bb0335","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.7150\/thno.34031","article-title":"A versatile supramolecular nanoadjuvant that activates NF-kappaB for cancer immunotherapy","volume":"9","author":"Xu","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.bioorg.2026.109861_bb0340","doi-asserted-by":"crossref","first-page":"6217","DOI":"10.1039\/D2BM01242A","article-title":"Multidomain peptide hydrogel adjuvants elicit strong bias towards humoral immunity","volume":"10","author":"Pogostin","year":"2022","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.bioorg.2026.109861_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.126513","article-title":"Investigation of physical mixtures versus disulfide crosslinking self-adjuvanting peptide-based subunit vaccines against group a streptococcus","volume":"689","author":"Fan","year":"2026","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioorg.2026.109861_bb0350","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1186\/s12885-019-5725-y","article-title":"Vaccination with synthetic long peptide formulated with CpG in an oil-in-water emulsion induces robust e7-specific CD8 t cell responses and TC-1 tumor eradication","volume":"19","author":"Maynard","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bioorg.2026.109861_bb0355","doi-asserted-by":"crossref","first-page":"14661","DOI":"10.1038\/s41598-021-94250-0","article-title":"Ex vivo dendritic cell-based (DC) vaccine pulsed with a low dose of liposomal antigen and CpG-ODN improved PD-1 blockade immunotherapy","volume":"11","author":"Yazdani","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.109861_bb0360","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s40264-015-0350-4","article-title":"Comparative safety of vaccine adjuvants: a summary of current evidence and future needs","volume":"38","author":"Petrovsky","year":"2015","journal-title":"Drug Saf."},{"key":"10.1016\/j.bioorg.2026.109861_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2010.09.007","article-title":"The germinal center reaction","volume":"126","author":"Gatto","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.bioorg.2026.109861_bb0370","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.immuni.2021.03.013","article-title":"Positive selection of IgG(+) over IgM(+) b cells in the germinal center reaction","volume":"54","author":"Sundling","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.bioorg.2026.109861_bb0375","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1146\/annurev-immunol-051116-052510","article-title":"Self-reactive b cells in the germinal center reaction","volume":"36","author":"Brink","year":"2018","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bioorg.2026.109861_bb0380","doi-asserted-by":"crossref","first-page":"7753","DOI":"10.1038\/srep07753","article-title":"Zinc-triggered hydrogelation of self-assembled small molecules to inhibit bacterial growth","volume":"5","author":"Xu","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.109861_bb0385","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1111\/bph.15387","article-title":"Targeting macrophage liver x receptors by hydrogel-encapsulated t0901317 reduces atherosclerosis without effect on hepatic lipogenesis","volume":"178","author":"Ma","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.109861_bb0390","doi-asserted-by":"crossref","first-page":"eaba0995","DOI":"10.1126\/sciadv.aba0995","article-title":"Adjuvant-free nanofiber vaccine induces in situ lung dendritic cell activation and T(H)17 responses","volume":"6","author":"Si","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bioorg.2026.109861_bb0395","doi-asserted-by":"crossref","first-page":"eabq0273","DOI":"10.1126\/sciadv.abq0273","article-title":"Self-assembling peptide nanofiber HIV vaccine elicits robust vaccine-induced antibody functions and modulates fc glycosylation","volume":"8","author":"Chen","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bioorg.2026.109861_bb0400","doi-asserted-by":"crossref","first-page":"eabq4120","DOI":"10.1126\/sciadv.abq4120","article-title":"A sublingual nanofiber vaccine to prevent urinary tract infections","volume":"8","author":"Kelly","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bioorg.2026.109861_bb0405","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.it.2015.05.007","article-title":"Harnessing nanoparticles for immune modulation","volume":"36","author":"Getts","year":"2015","journal-title":"Trends Immunol."},{"key":"10.1016\/j.bioorg.2026.109861_bb0410","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1023\/A:1010067107182","article-title":"Dynamic light scattering measurement of nanometer particles in liquids","volume":"2","author":"Pecora","year":"2000","journal-title":"J. Nanopart. Res."},{"key":"10.1016\/j.bioorg.2026.109861_bb0415","doi-asserted-by":"crossref","first-page":"4930","DOI":"10.1073\/pnas.0600997103","article-title":"Role of target geometry in phagocytosis","volume":"103","author":"Champion","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bioorg.2026.109861_bb0420","doi-asserted-by":"crossref","first-page":"eabm7833","DOI":"10.1126\/sciadv.abm7833","article-title":"Multiepitope supramolecular peptide nanofibers eliciting coordinated humoral and cellular antitumor immune responses","volume":"8","author":"Wu","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bioorg.2026.109861_bb0425","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nri2868","article-title":"Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns","volume":"10","author":"Bachmann","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bioorg.2026.109861_bb0430","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.1021\/acsabm.2c00716","article-title":"Pairing nanoparticles geometry with TLR agonists to modulate immune responses for vaccine development","volume":"5","author":"Bhoge","year":"2022","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.bioorg.2026.109861_bb0435","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jconrel.2015.09.069","article-title":"Shape and size-dependent immune response to antigen-carrying nanoparticles","volume":"220","author":"Kumar","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioorg.2026.109861_bb0440","doi-asserted-by":"crossref","first-page":"16728","DOI":"10.1038\/srep16728","article-title":"Virus-like nanostructures for tuning immune response","volume":"5","author":"Mammadov","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.109861_bb0445","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1039\/C4OB00447G","article-title":"Self-assembly of peptides to nanostructures","volume":"12","author":"Mandal","year":"2014","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bioorg.2026.109861_bb0450","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/978-1-59745-480-3_5","article-title":"Synthesis and primary characterization of self-assembled peptide-based hydrogels","volume":"474","author":"Nagarkar","year":"2008","journal-title":"Methods Mol. Biol."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826003974?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826003974?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:40:57Z","timestamp":1777452057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826003974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":90,"alternative-id":["S0045206826003974"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109861","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A non-conjugated peptide-adjuvant system of synthetic peptide-vaccine elicited potent antibody response and opsonic protection against clinical GAS strains","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109861","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109861"}}